12885_2022_10109_MOESM4_ESM.docx (56.02 kB)
Additional file 4 of EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
journal contribution
posted on 2022-10-05, 07:04 authored by Jonas Leichsenring, Valentina Vladimirova, Christine Solbach, Thomas Karn, Beyhan Ataseven, Bruno Valentin Sinn, Jana Barinoff, Volkmar Müller, Jens-Uwe Blohmer, Christian Schem, Knut Engels, Frederik Marmé, Annette Fisseler-Eckhoff, Peter A. Fasching, Elmar Stickeler, Marion van Mackelenbergh, Carsten Denkert, Albrecht Stenzinger, Sibylle Loibl, Stefan GröschelAdditional file 4: Supplementary Table 1. Correlation of baseline patient and tumor characteristics with EVI1 expression among BC subtypes. Supplementary Table 2. Multivariate analysis of EVI1 prognostic value in the entire cohort. Supplementary Table 3. pCR (ypT0 ypN0) rates overall and among breast cancer subtypes. Supplementary Table 4. Multivariate analysis of EVI1 prognostic value across BC subtypes. Supplementary Table 5. Univariate analysis of EVI1 prognostic value in patients with residual disease overall and among BC subtypes.
